Bala Mohan Insider Trades

Insider Trading History

Track insider trading activity for Bala Mohan. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Tender)Reported as Tender on SEC Form 4.
$85.1k 2,927 shares
$29.08
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development
Holding Value $0 0 shares
Last Trade
Jan 06, 2026 Sale (Sale to Issuer)Shares sold back to the company, such as a repurchase or tender.
$798k 27,435 shares
$29.08
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $85k 2,922 shares
Last Trade
Oct 27, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$762 77 shares
$9.90
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $87.2k 2,999 shares
Last Trade
Oct 25, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.45k 250 shares
$9.78
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $0 0 shares
Last Trade
Oct 25, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.45k 250 shares
$9.78
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $2M 68,872 shares
Last Trade
Jan 16, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$91.2k 5,939 shares
$15.35
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $8.18M 281,250 shares
Last Trade
Jan 15, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.51M 281,250 shares
$16.02
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $2.18M 74,811 shares
Last Trade
Jan 15, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$234k 14,583 shares
$16.02
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $1.27M 43,750 shares
Last Trade
Jan 15, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$234k 14,583 shares
$16.02
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $1.75M 60,228 shares
Last Trade
Jan 14, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$51.6k 3,253 shares
$15.85
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $1.85M 63,481 shares
Last Trade
Jan 13, 2025 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$136k 8,750 shares
$15.55
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $509k 17,500 shares
Last Trade
Jan 13, 2025 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$136k 8,750 shares
$15.55
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $1.59M 54,731 shares
Last Trade
Oct 28, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$96.1k 1,884 shares
$51.00
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $182k 6,250 shares
Last Trade
Oct 25, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$297k 6,250 shares
$47.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $1.65M 56,615 shares
Last Trade
Oct 25, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$297k 6,250 shares
$47.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $1.46M 50,365 shares
Last Trade
Oct 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$283k 5,598 shares
$50.50
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $1.63M 55,963 shares
Last Trade
Oct 02, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$413k 8,089 shares
$51.00
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $0 0 shares
Last Trade
Oct 01, 2024 Sale (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.29M 50,000 shares
$45.75
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $1.86M 64,052 shares
Last Trade
Oct 01, 2024 Purchase (Option Exercise)Shares acquired or sold by exercising stock options or converting another derivative security.
$2.29M 50,000 shares
$45.75
$29.08
Mersana Therapeutics
Mersana Therapeutics MRSN
Svp, Chief Development Officer
Holding Value $409k 14,052 shares
Last Trade
Jan 16, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$232k 3,431 shares
$67.75
$29.08

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up